Related Experiment Video
Updated: May 22, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pulmonary Infections in Adults: Pulmonary Infections in Immunocompromised Patients
Julio A Ramirez1, Thomas M File2
1Norton Infectious Diseases Institute, Louisville, KY.
Pneumonia in immunocompromised patients requires prompt microbiological evaluation. Tailor invasive workups and consider empiric therapy for opportunistic pathogens to improve outcomes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Immunology
Background:
- Immunocompromised patients are susceptible to both common and opportunistic pulmonary pathogens.
- Pneumonia in this population presents unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To outline diagnostic and therapeutic strategies for pneumonia in immunocompromised patients.
- To emphasize individualized workup and management based on patient risk factors.
Main Methods:
- Recommend a basic microbiological workup for all hospitalized or outpatient immunocompromised patients with pneumonia.
- Advocate for individualized, more invasive workups (e.g., bronchoscopy) based on opportunistic pathogen risk factors.
- Stress the importance of evaluating and potentially reducing immunosuppressive medications.
Main Results:
- A systematic approach to diagnosis and treatment is crucial for managing pneumonia in immunocompromised individuals.
- Early consideration of empiric therapy for opportunistic pathogens can mitigate mortality risk.
Conclusions:
- Prompt and tailored diagnostic evaluation is essential for immunocompromised patients with pneumonia.
- Adjusting immunosuppressive therapy and considering empiric treatment for opportunistic infections are key management components.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology